Search the Newsreel

Zimmer Biomet - ZIM - Stock Price & News

This article provides a detailed financial overview of Zimmer Biomet (ZIM), a company specializing in orthopedic reconstructive products. It includes stock performance metrics, market capitalization, key financial ratios like revenue, net income, and EPS, along with annual and quarterly growth comparisons. The content also …

Top BitMine Immersion Technologies (BMNR) Competitors 2026

147,000 Shares in ImmunityBio, Inc. $IBRX Purchased by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. acquired 147,000 shares of ImmunityBio, Inc. (IBRX) during the second quarter, valued at approximately $1.29 million. Institutional investors now hold 8.58% of the company, while corporate insiders own 66.10%, despite recent insider selling totaling about $3.92 million. ImmunityBio reported a …

Tom Lee's Bitmine Continues to Buy Ethereum, Now Holds 4.8% of Its Total Supply. Should Investors Follow His Lead and Buy ETH?

Tom Lee, the founder of Fundstrat Global Advisors and prolific crypto bull, joined Bitmine (NYSE: BMNR) as its chairman last year. Under Lee, Bitmine evolved from a Bitcoin (CRYPTO: BTC) miner into the world's largest corporate holder of Ethereum (CRYPTO: ETH). As of Aug. …

Renaissance Technologies LLC Invests $1.02 Million in Immunic, Inc. $IMUX

Renaissance Technologies LLC has acquired 919,164 shares of Immunic, Inc. (NASDAQ:IMUX) valued at approximately $1.02 million, giving it a 6.75% stake in the biopharmaceutical company. Immunic, which develops oral therapies for autoimmune diseases, recently reported better-than-expected quarterly earnings and maintains a consensus "Buy" rating …

Form 8K Bitmine Immersion Technologies Inc For: 14 August By Investing.com

This article announces that Bitmine Immersion Technologies Inc. filed a Form 8K on August 14. It briefly mentions the company's stock symbol BMNR and provides a negative percentage change for it. The rest of the content includes various market data, news headlines, and promotional …

Immunome (NASDAQ:IMNM) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Immunome (NASDAQ:IMNM) to a "strong sell" rating, contrasting with the broader analyst consensus of "Moderate Buy" and a price target of $34.64. This downgrade follows Immunome reporting a quarterly loss of $0.65 per share, missing estimates, with full-year losses …

Everett Harris & Co. CA Invests $2.55 Million in Zimmer Biomet Holdings, Inc. $ZBH

Everett Harris & Co. CA recently acquired a new stake of 29,647 shares, valued at approximately $2.55 million, in Zimmer Biomet Holdings, Inc. during the second quarter. Other institutional investors have also adjusted their holdings in ZBH, which currently has 88.89% institutional ownership. Zimmer …

IBRX Stock Eyes Green Open Ahead Of Earnings — What Happened With Anktiva Over The Weekend

Dimensional Fund Advisors LP Sells 103,356 Shares of Immunovant, Inc. $IMVT

Dimensional Fund Advisors LP significantly reduced its stake in Immunovant, Inc. (NASDAQ:IMVT) by selling 103,356 shares, retaining 57,086 shares valued at $1.42 million. This comes as Immunovant's insiders, including the CTO and COO, also sold a substantial number of shares recently. Analysts currently rate …

BITMINE IMMERSION TECHNOLOGIES INC 9.5 SER A CUM PREF STK To Go Ex-Dividend On October 27th, 2026 With 0.1583 USD Dividend Per Share

BITMINE IMMERSION TECHNOLOGIES INC's 9.5 Series A Cumulative Preferred Stock (OTCMKTS:BMTM-PA) is set to go ex-dividend on October 27th, 2026. Shareholders will receive a dividend of $0.1583 per share. This upcoming dividend distribution should be noted by investors.

IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook

IBRX Stock To Open Week On A High? Chairman Teases Anktiva’s 3-Year Expansion Plans, Hints At Cancer Breakthrough

Nasdaq, S&P 500 Futures Rise Ahead Of Nvidia Earnings, Fed Minutes: Why TSLA, SLS, IBRX, CAVA, POET, BA Are In Focus

ImmuCell Corporation - Common Stock (ICCC) Stock Price, News, Quote & History

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.70 Million Tokens, and Total Crypto and Total Cash Holdings of $9.8 Billion | Corporate

Bitmine Immersion Technologies (BMNR) has announced that its ETH holdings have reached 5.70 million tokens, contributing to total crypto and cash holdings of $9.8 billion. The company holds 4.7% of the total ETH coin supply and was recently added to the Russell 1000 Large-cap …

Immatics (IMTX): Baker Bros. group reports 9.5M-share, 7% ownership stake

Baker Bros. Advisors LP and related entities have filed an amendment to report a 7.0% ownership stake in Immatics N.V. (IMTX), totaling 9,508,565 ordinary shares. These shares are beneficially owned through Baker Brothers Life Sciences, L.P. and 667, L.P., with the reporting persons holding …

Why Immunovant (IMVT) Is Up 5.2% After Wider Q1 Loss, Moderna Cash, And Pivotal Data Hype

Lyell Immunopharma (LYEL): Foresite funds and Tananbaum report 2.7% ownership

Foresite Capital-affiliated funds and James B. Tananbaum have reported a beneficial ownership of 653,328 shares of Lyell Immunopharma (LYEL) common stock, representing 2.7% of the class. This disclosure was made in an updated SCHEDULE 13G/A SEC filing. The ownership is primarily held by Foresite …

Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock

Bitmine Immersion Technologies announced the record and payment dates for its cash dividends on the 9.50% Series A Perpetual Preferred Stock. This announcement is related to previous news regarding the company's dividend declarations, NYSE listing, and proposed stock offerings. The company also recently reported …

Immersion Corp (IMMR) files Form 13F showing $178.7M across 7 holdings

Immersion Corp (IMMR), an institutional investment manager, has filed a Form 13F holdings report disclosing 7 reportable holdings with an aggregate value of $178,728,110. The filing also indicates two other associated managers for these positions. Eric Singer, President, CEO, and Chairman, signed the report.

ImmuCell Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ICCC) 2026-08-14

Cormorant Asset Management (MLTX) discloses 4.35% MoonLake Immunotherapeutics stake

Cormorant Asset Management, LP and Bihua Chen have disclosed a 4.35% beneficial ownership stake in MoonLake Immunotherapeutics (MLTX), totaling 3,205,433 Class A ordinary shares. This stake, reported via a SCHEDULE 13G/A filing, indicates shared voting and dispositive power over the shares and is based …

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 4.5% - Here's Why

Immix Biopharma (NASDAQ: IMMX) shares dropped 4.5% to $10.43 on Friday, with trading volume significantly below average. This decline followed the company missing its latest quarterly earnings estimate, reporting a loss of $0.18 per share against an expected $0.17 loss. Despite the recent dip, …

Immix Biopharma (IMMX) gains 5.6% stake holder led by Eventide Asset Management

Eventide Asset Management, LLC, through its Eventide Healthcare & Life Sciences Fund, has reported a beneficial ownership of 3,891,019 shares of Immix Biopharma (IMMX) common stock, representing a 5.6% stake. This Schedule 13G filing indicates that Eventide holds sole voting and dispositive power over …

T. Rowe Price Investment Management (IMNM) discloses 17.4% Immunome ownership, key fund at 6.5%

T. Rowe Price Investment Management, Inc. has reported a beneficial ownership of 17.4% of Immunome, Inc. common stock, totaling 19,676,883 shares, according to a recent SEC filing. The firm holds sole voting power over 19,656,814 shares and sole dispositive power over all 19,676,883 shares. …

ImmuCell Q2 2026 slides: revenue gains offset by margin pressure

ImmuCell (NASDAQ:ICCC) reported mixed Q2 2026 results, with product sales up 11.5% to $7.2 million, but gross margin significantly compressed from 43.7% to 33.9%. Despite a tripling of net income to $1.8 million largely due to a $2 million legal settlement, the stock dropped …

ImmuCell Corporation - Common Stock ICCC

ImmuCell Corporation (ICCC) is a biotechnology company focused on veterinary products, particularly for enhancing immune health in livestock. The company's stock recently traded at $10.20, down 6.47%, and has a market cap of $78.93 million. Recent news highlights include Q2 2026 earnings results, increased …

ImmuCell Q2 Earnings Call Highlights

Key Points Interested in ImmuCell Corporation? Here are five stocks we like better. Strong domestic growth drove results: Second-quarter product sales rose 11.5% year over year to $7.2 million, while net income increased to $1.8 million from $500,000. Domestic sales grew 27.7%, offsetting a …

Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake

Armistice Capital, LLC and Steven Boyd have disclosed a 4.99% beneficial ownership stake in Estrella Immunopharma, Inc. (ESLA) common stock. This translates to 2,051,409 shares, over which they hold shared voting and dispositive power. The shares are held by Armistice Capital Master Fund Ltd., …

Earnings call transcript: ImmuCell posts strong Q2 2026 sales growth, shares fall

Bitmine schedules 17 cash dividend payments for BMNP through Dec. 28

Bitmine Immersion Technologies (NYSE: BMNP, BMNR) has declared seventeen cash dividends on its 9.50% Series A Perpetual Preferred Stock. These dividends, with amounts ranging from $0.1583 to $0.2639 per share, have record dates between August 25 and December 18, 2026, and payment dates from …

Bitmine Immersion (BMNP) schedules 17 cash dividends on Series A preferred

Bitmine Immersion Technologies (BMNP) has announced that its Board of Directors declared seventeen cash dividends for its 9.50% Series A Perpetual Preferred Stock. These dividends will be paid in cash, with record dates spanning from August 25, 2026, through December 18, 2026, and corresponding …